UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$388M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$359M |
| 3 |
ExxonMobil
XOM
|
+$284M |
| 4 |
TSMC
TSM
|
+$259M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$239M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$911M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$825M |
| 3 |
UBS Group
UBS
|
+$683M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$381M |
| 5 |
Willis Towers Watson
WTW
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.08% |
| 2 | Financials | 7.19% |
| 3 | Healthcare | 6.35% |
| 4 | Consumer Discretionary | 5.55% |
| 5 | Industrials | 4.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCOB
3726
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
| $1.48M | ﹤0.01% |
151,200
+1,200
| +0.8% | +$11.7K |
|
|
AFAQ
3727
DELISTED
AF Acquisition Corp
AFAQ
| $1.48M | ﹤0.01% |
151,505
+151,228
| +54,595% | +$1.47M |
|
3728
Old National Bancorp
ONB
$10.4B
| $1.48M | ﹤0.01% |
90,079
+54,933
| +156% | +$1M |
|
|
ORC
3729
Orchid Island Capital
ORC
$1.32B
| $1.47M | ﹤0.01% |
90,723
+16,168
| +22% | +$305K |
|
3730
PUT
Polaris
PII
$3.91B
| $1.47M | ﹤0.01% |
+14,000
| New | +$1.6M |
|
3731
State Street SPDR S&P Insurance ETF
KIE
$681M
| $1.47M | ﹤0.01% |
35,041
+11,999
| +52% | +$483K |
|
3732
Dorman Products
DORM
$3.95B
| $1.47M | ﹤0.01% |
15,492
-20,202
| -57% | -$1.96M |
|
3733
Idacorp
IDA
$8.16B
| $1.47M | ﹤0.01% |
12,747
-22,114
| -63% | -$2.41M |
|
3734
Barron's 400 ETF
BFOR
$238M
| $1.47M | ﹤0.01% |
99,108
+12,688
| +15% | +$189K |
|
|
CHX
3735
DELISTED
ChampionX
CHX
| $1.47M | ﹤0.01% |
60,021
-136,505
| -69% | -$3.16M |
|
3736
Portillo's
PTLO
$365M
| $1.47M | ﹤0.01% |
59,738
-47,284
| -44% | -$1.25M |
|
3737
CALL
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $1.47M | ﹤0.01% |
+15,000
| New | +$1.52M |
|
|
EVRI
3738
CALL
DELISTED
Everi Holdings
EVRI
| $1.46M | ﹤0.01% |
+69,700
| New | +$1.48M |
|
|
EVRI
3739
PUT
DELISTED
Everi Holdings
EVRI
| $1.46M | ﹤0.01% |
+69,700
| New | +$1.48M |
|
3740
TG Therapeutics
TGTX
$7.34B
| $1.46M | ﹤0.01% |
153,923
-99,869
| -39% | -$1.16M |
|
3741
CALL
Prothena Corp
PRTA
$466M
| $1.46M | ﹤0.01% |
+40,000
| New | +$1.44M |
|
3742
Vericel Corp
VCEL
$2.28B
| $1.46M | ﹤0.01% |
38,243
-77,261
| -67% | -$2.79M |
|
3743
Terex
TEX
$7.57B
| $1.46M | ﹤0.01% |
40,952
-26,572
| -39% | -$1.1M |
|
3744
Vaxcyte
PCVX
$8.76B
| $1.46M | ﹤0.01% |
60,387
+15,152
| +33% | +$331K |
|
3745
ALX Oncology
ALXO
$268M
| $1.46M | ﹤0.01% |
86,072
-7,726
| -8% | -$132K |
|
3746
CALL
International Paper
IP
$21.8B
| $1.45M | ﹤0.01% |
31,471
-59,565
| -65% | -$2.74M |
|
3747
Atlantic Union Bankshares
AUB
$6.09B
| $1.45M | ﹤0.01% |
39,380
-13,178
| -25% | -$526K |
|
3748
MGP Ingredients
MGPI
$389M
| $1.44M | ﹤0.01% |
16,828
+2,126
| +14% | +$171K |
|
3749
Liberty Global Class A
LBTYA
$3.58B
| $1.44M | ﹤0.01% |
56,435
-15,432
| -21% | -$409K |
|
|
THS
3750
DELISTED
Treehouse Foods
THS
| $1.44M | ﹤0.01% |
44,558
-34,802
| -44% | -$1.31M |
|
Similar funds
UBS Group's Q1 2022 Portfolio in Review
As of Q1 2022, UBS Group held 11,668 positions worth $300B, down 14% from $349B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group withdrew a net $29.5B in Q1 2022, closing 1,161 positions and reducing 5,174 holdings. Its most notable exit was Xilinx Inc, an estimated $186M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in Shell worth $66.6M.
- UBS Group's largest Q1 2022 buy was Shell: 1,213,213 shares worth $66.6M.
- UBS Group added most to Tesla in Q1 2022, an estimated $388M increase.
- UBS Group's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $911M.
- UBS Group fully exited Xilinx Inc in Q1 2022, selling an estimated $186M.
- UBS Group's ten largest holdings make up 13% of its $300B portfolio in Q1 2022.
- UBS Group opened 1,181 new positions and closed 1,161 in Q1 2022.
- UBS Group's portfolio value fell 14% quarter-over-quarter to $300B.
Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.